A designed autoregulated MBNL1 overexpression system, a prototype of a gene therapy tool, enables production of MBNL1 protein in cells with low activity of this protein caused by its pathogenic sequestration on toxic RNA containing CUG expansion in myotonic dystrophy (DM). Here, MBNL1 is linked to myotonic dystrophy.